Velpanat tablets supplier USA

Velpanat is a fixed-dose combination antiviral medication used for the treatment of chronic Hepatitis C virus (HCV) infection, covering all six major genotypes (1-6). Each tablet contains Sofosbuvir 400 mg and Velpatasvir 100 mg, making it a convenient, once-daily oral treatment that offers a high cure rate across diverse patient populations.

Velpanat is a breakthrough, pangenotypic, direct-acting antiviral (DAA) medication developed by Natco Pharma for the treatment of chronic Hepatitis C infection in adults. It contains two potent antiviral agents:

• Sofosbuvir (400 mg) – an NS5B polymerase inhibitor

• Velpatasvir (100 mg) – an NS5A inhibitor

Together, these drugs work synergistically to stop the hepatitis C virus from replicating and spreading in the body. Velpanat is especially effective because it can treat all genotypes of HCV (1 through 6), reducing the need for genotype-specific regimens.

Velpanat is typically administered once daily for 12 weeks, with or without Ribavirin based on the patient’s liver condition (e.g., decompensated cirrhosis).

Key Features:

• Contains Sofosbuvir 400 mg + Velpatasvir 100 mg

• Pangenotypic – treats genotypes 1 to 6 of HCV

• High cure rates (SVR >95%) after a 12-week treatment course

• No need for interferon or multiple pills

• Manufactured by Natco Pharma Ltd, a trusted name in Hepatitis C treatment

• WHO-prequalified and widely used in global treatment programs

Indications:

• Chronic Hepatitis C infection (genotypes 1–6)

• With or without compensated or decompensated cirrhosis

• Suitable for treatment-naïve or treatment-experienced adults

Dosage and Administration:

• Standard dose: One tablet once daily, with or without food

• Treatment duration: Typically 12 weeks; may be 24 weeks in patients with decompensated cirrhosis (often with Ribavirin)

• Follow your doctor’s complete instructions for optimal results

Precautions:

• Not recommended during pregnancy (especially if combined with Ribavirin)

• Use with caution in patients with severe liver or kidney disease

• May interact with other medications, especially antacids, anticonvulsants, and HIV drugs

• Inform your doctor of any pre-existing conditions, including co-infection with HIV or Hepatitis B

Storage Instructions:

• Store at room temperature below 30°C

• Keep away from moisture, heat, and direct sunlight

• Keep out of reach of children